Rydex Biotechnology Fund Class C (RYCFX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
46.82
+0.45 (0.97%)
At close: Jun 17, 2026
RYCFX Holdings Information
RYCFX is a mutual fund with a total of 75 individual holdings. The top holdings are AbbVie stock at 7.39%, Amgen at 5.23%, Gilead Sciences at 4.96%, Vertex Pharmaceuticals at 4.01%, and Regeneron Pharmaceuticals at 3.56%.
Total Holdings
75
Top 10 Percentage
36.66%
Asset Class
Equity
Fund Category
Health
Assets
115.29M
Forward PE Ratio
16.63
Breakdown by Asset Class
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | 7.39% |
| 2 | AMGN | Amgen Inc. | 5.23% |
| 3 | GILD | Gilead Sciences, Inc. | 4.96% |
| 4 | VRTX | Vertex Pharmaceuticals Incorporated | 4.01% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 3.56% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.60% |
| 7 | INSM | Insmed Incorporated | 2.45% |
| 8 | ONC | BeOne Medicines AG | 2.29% |
| 9 | NTRA | Natera, Inc. | 2.09% |
| 10 | UTHR | United Therapeutics Corporation | 2.07% |
| 11 | BIIB | Biogen Inc. | 2.01% |
| 12 | RPRX | Royalty Pharma plc | 1.98% |
| 13 | ILMN | Illumina, Inc. | 1.74% |
| 14 | RVMD | Revolution Medicines, Inc. | 1.69% |
| 15 | MRNA | Moderna, Inc. | 1.65% |
| 16 | AZN | AstraZeneca PLC | 1.60% |
| 17 | ARGX | argenx SE | 1.60% |
| 18 | INCY | Incyte Corporation | 1.56% |
| 19 | VTRS | Viatris Inc. | 1.50% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.47% |
| 21 | ALKS | Alkermes plc | 1.47% |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 1.46% |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 1.42% |
| 24 | GH | Guardant Health, Inc. | 1.41% |
| 25 | ROIV | Roivant Sciences Ltd. | 1.40% |
As of Mar 31, 2026